International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

Deucravacitinib: Efficacy and Safety Results from the Phase 3 Trials

Deucravacitinib: Efficacy and Safety Results from the Phase 3 Trials

Richard Warren, BSc, MBChB, MRCP, PhD | United Kingdom
2022

Featured Experts